Involvement of interleukin 18 in indomethacin-induced lesions of the gastric mucosa in adjuvant-induced arthritis rat

Toxicology

Volumn 255, Issue 3, 2009, Pages 124-130

  Nagai, Noriaki ^a   Fukuhata, Takashi ^a   Ito, Yoshimasa ^a,b   Usui, Shigeyuki ^c   Hirano, Kazuyuki ^c  

^a School of Pharmaceutical Sciences   (Japan)

^b KINKI UNIVERSITY   (Japan)

^c GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Adjuvant induced arthritis; Gastric lesion; Indomethacin; Interleukin 18; Rheumatoid arthritis

Indexed keywords

ETHER; GAMMA INTERFERON; INDOMETACIN; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR ALPHA; INTERLEUKIN 18 RECEPTOR BETA; INTERLEUKIN 18BP; INTERLEUKIN 1BETA CONVERTING ENZYME; NITRIC OXIDE; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DARK AGOUTI RAT; DISEASE EXACERBATION; MYCOBACTERIUM BUTYRICUM; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH LESION; STOMACH MUCOSA;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, EXPERIMENTAL; BASE SEQUENCE; CASPASE 1; DNA PRIMERS; GASTRIC MUCOSA; INDOMETHACIN; INTERFERON-GAMMA; INTERLEUKIN-18; MALE; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

AGOUTI; MYCOBACTERIUM BUTYRICUM; RATTUS;

EID: 58149161550     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2008.10.005     Document Type: Article

References (25)

1. Aizawa Y., Akita K., Taniai M., Torigoe K., Mori T., Nishida Y., Ushio S., Nukada Y., Tanimoto T., Ikegami H., Ikeda M., and Kurimoto M. Cloning and expression of interleukin-18 binding protein. FEBS. Lett. 445 (1999) 338-342
2. Billingham M.E. Models of arthritis and the search for anti-arthritic drugs. Pharmacol. Ther. 21 (1983) 389-428
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
4. Burbach G.J., Naik S.M., Harten J.B., Liu L., Dithmar S., Grossniklaus H., Ward S.L., Armstrong C.A., Caughman S.W., and Ansel J.C. Interleukin-18 expression and modulation in human corneal epithelial cells. Curr. Eye Res. 23 (2001) 64-68
5. Chen C.W., Chang Y.H., Tsi C.J., and Lin W.W. Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway. J. Immunol. 171 (2003) 979-988
6. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
7. Escandell J.M., Recio M.C., Manez S., Giner R.M., Cerda N.M., and Rios J.L. Cucurbitacin R reduces the inflammation and bone damage associated with adjuvant arthritis in lewis rats by suppression of tumor necrosis factor-alpha in T lymphocytes and macrophages. J. Pharmacol. Exp. Ther. 320 (2007) 581-590
8. Ghayur T., Banerjee S., Hugunin M., Butler D., Herzog L., Carter A., Quintal L., Sekut L., Talanian R., Paskind M., Wong W., Kamen R., Tracey D., and Allen H. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 386 (1997) 619-623
9. Gu Y., Kuida K., Tsutsui H., Ku G., Hsiao K., Fleming M.A., Hayashi N., Higashino K., Okamura H., Nakanishi K., Kurimoto M., Tanimoto T., Flavell R.A., Sato V., Harding M.W., Livingston D.J., and Su M.S. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 275 (1997) 206-209
10. Heitmeier M.R., Scarim A.L., and Corbett J.A. Interferon-gamma increases the sensitivity of islets of Langerhans for inducible nitric-oxide synthase expression induced by interleukin 1. J. Biol. Chem. 272 (1997) 13697-13704
11. Heitmeier M.R., Scarim A.L., and Corbett J.A. Prolonged STAT1 activation is associated with interferon-gamma priming for interleukin-1-induced inducible nitric-oxide synthase expression by islets of Langerhans. J. Biol. Chem. 274 (1999) 29266-29273
12. Hoshino K., Tsutsui H., Kawai T., Takeda K., Nakanishi K., Takeda Y., and Akira S. Cutting edge: generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor. J. Immunol. 162 (1999) 5041-5044
13. Hultqvist M., Olofsson P., Gelderman K.A., Holmberg J., and Holmdahl R. A new arthritis therapy with oxidative burst inducers. PLoS Med. 3 (2006) e348
14. Hurgin V., Novick D., and Rubinstein M. The promoter of IL-18 binding protein: activation by an IFN-gamma -induced complex of IFN regulatory factor 1 and CCAAT/enhancer binding protein beta. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 16957-16962
15. Kato S., Ogawa Y., Kanatsu K., Okayama M., Watanabe T., Arakawa T., and Takeuchi K. Ulcerogenic influence of selective cyclooxygenase-2 inhibitors in the rat stomach with adjuvant-induced arthritis. J. Pharmacol. Exp. Ther. 303 (2002) 503-509
16. Kato S. Changes in ulcerogenic response to non-steroidal anti-inflammatory drugs (NSAIDs) in adjuvant arthritic rat. YAKUGAKU ZASSHI 121 (2001) 743-751
17. Kato S., and Takeuchi K. Alteration of gastric ulcerogenic and healing responses in rats with adjuvant-induced arthritis. Jpn. J. Pharmacol. 89 (2002) 1-6
18. Kim S.H., Reznikov L.L., Stuyt R.J., Selzman C.H., Fantuzzi G., Hoshino T., Young H.A., and Dinarello C.A. Functional reconstitution and regulation of IL-18 activity by the IL-18R beta chain. J. Immunol. 166 (2001) 148-154
19. Nakanishi K., Yoshimoto T., Tsutsui H., and Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 19 (2001) 423-474
20. Novick D., Kim S.H., Fantuzzi G., Reznikov L.L., Dinarello C.A., and Rubinstein M. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 10 (1999) 127-136
21. Sakuma S., Nishigaki F., Magari K., Ogawa T., Miyata S., Ohkubo Y., and Goto T. FK506 is superior to methotrexate in therapeutic effects on advanced stage of rat adjuvant-induced arthritis. Inflamm. Res. 50 (2001) 509-514
22. Sugawara S., Uehara A., Nochi T., Yamaguchi T., Ueda H., Sugiyama A., Hanzawa K., Kumagai K., Okamura H., and Takada H. Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells. J. Immunol. 167 (2001) 6568-6575
23. Torigoe K., Ushio S., Okura T., Kobayashi S., Taniai M., Kunikata T., Murakami T., Sanou O., Kojima H., Fujii M., Ohta T., Ikeda M., Ikegami H., and Kurimoto M. Purification and characterization of the human interleukin-18 receptor. J. Biol. Chem. 272 (1997) 25737-25742
24. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New Biol. 231 (1971) 232-235
25. Whittle B.J. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 80 (1981) 94-98